Latest News for: antibes

Edit

Antibe Announces Appointment of Receiver

Business Wire 24 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Appointment of Receiver ... .
Edit

Antibe Provides Update on CCAA Proceedings

Business Wire 19 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Provides Update on CCAA Proceedings ... .
Edit

Antibe Announces TSX Delisting Review

Business Wire 16 Apr 2024
TORONTO--(BUSINESS WIRE)--Antibe Announces TSX Delisting Review ... .
Edit

Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act

Business Wire 10 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Granting of Initial Order under Companies' Creditors Arrangement Act ... .
Edit

Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act

Business Wire 09 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe to File an Application for an Initial Order under Companies' Creditors Arrangement Act ... .
Edit

Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Business Wire 01 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE ANNOUNCES FDA CLINICAL HOLD ON OTENAPROXESUL AND LEGAL ACTION BY NUANCE ... .
Edit

Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting

Business Wire 20 Mar 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE TO PRESENT OTENAPROXESUL PK/PD RESULTS AT THE ASRA PAIN MEDICINE MEETING ... .
Edit

Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma

Business Wire 04 Mar 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma ... .
Edit

Antibe Therapeutics Shares Sink After Arbitration Case Lost

Market Watch 04 Mar 2024
Antibe Therapeutics' shares were down sharply after the biotechnology company lost a dispute in arbitration over a license agreement for the commercialization of its lead drug candidate in the Greater China region.
×